Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis

By Kearon C.   Harrison L.   Crowther M.   Ginsberg J.S.  

Thrombosis Research, Vol. 97, Iss. 6, 2000-03 ,pp. : 395-403

Elsevier

Access to resources Recommend Favorite

Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin

By Ulander V.-M.   Lehtola A.   Kaaja R.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 239-242

Elsevier

Access to resources Recommend Favorite

Low Molecular Weight Heparins - Are They Superior to Unfractionated Heparins to Prevent and to Treat Deep Vein Thrombosis?

By Boneu B.  

Thrombosis Research, Vol. 100, Iss. 2, 2000-10 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

By Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 413-417

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite